Sign in

NCT06712433WithdrawnPhase 2

Bacterial Decolonization Plus Intraoperative Angiography for Soft Tissue Sarcomas Receiving Preoperative Radiotherapy (CONCERTO)

Bacterial Decolonization Plus Intraoperative Indocyanine Green Angiography for Soft Tissue Sarcomas of the Lower Extremity Receiving Preoperative Radiotherapy (CONCERTO)

Source: ClinicalTrials.gov · Last updated 26 Oct 2026

Brief summary (registry, in English)

This trial will investigate the combination of two low-cost, non-toxic strategies to assess whether they can reduce the risk of acute major wound complications in soft tissue sarcoma of the lower extremity. Intranasal mupirocin ointment twice daily and chlorhexidine body cleanser once daily for 5 days prior to radiation therapy and repeated for 5 days every 2 weeks during radiation therapy may significantly reduce the risk of acute radiation dermatitis. That, along with use of indocyanine green (ICG) angiography at the time of wound closure.

Status (registry)
Withdrawn
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
0 (actual)
First submitted
26 Nov 2024
Start date
30 Sept 2026
Primary completion date
30 Sept 2028
Lead sponsor
Adam Olson
Diseases
Sarcoma
NCT number
NCT06712433

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior RT overlapping with fields

Other illness

  • Allergy to mupirocin and/or chlorhexidine
  • Active dermatologic condition in RT field
  • Concurrent/prior invasive malignancy that could potentially interfere with proposed treatment. Individual cases can be discussed with PI prior to registration

Other

  • Tumor size > 32cm

Who the study is looking for

  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • Newly diagnosed soft tissue sarcoma arising from the lower extremity (defined as the tumor center arising at the level of the iliac crest or below)
  • Eligible for wide local excision
  • Eligible for external beam radiation therapy
  • Negative serum pregnancy test for women of childbearing potential < 28 days prior to RT.
  • Informed consent signed and dated to participate in the study.
  • Willingness and ability to comply

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
UPMC Hillman Cancer Centers
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.